处方药覆盖和药物利用:来自HRS处方药研究的新证据

Q3 Social Sciences Journal of Economic and Social Measurement Pub Date : 2016-01-01 DOI:10.3233/JEM-150418

Gary V. Engelhardt

{"title":"处方药覆盖和药物利用:来自HRS处方药研究的新证据","authors":"Gary V. Engelhardt","doi":"10.3233/JEM-150418","DOIUrl":null,"url":null,"abstract":"The linking of detailed information on health, medical care, and insurance to economic outcomes is a central feature of data collection efforts in the economics of aging. In this paper, I use newly available linked panel data from a unique supplement to the Health and Retirement Study (HRS) known as the Prescription Drug Study (PDS) to examine the impact of insurance coverage on prescription drug utilization for those 65 and older. Fixed-effect estimates suggest that gaining coverage resulted in a 15% increase in utilization. Gaining coverage also was associated with a 20-50% reduction in the incidence of cost-related non-adherence. However, even among the uninsured, only a relatively small proportion of drugs (12%) were associated with episodes of cost-related non-adherence.","PeriodicalId":53705,"journal":{"name":"Journal of Economic and Social Measurement","volume":"41 1","pages":"49-65"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/JEM-150418","citationCount":"3","resultStr":"{\"title\":\"Prescription drug coverage and drug utilization: New evidence from the HRS prescription drug study\",\"authors\":\"Gary V. Engelhardt\",\"doi\":\"10.3233/JEM-150418\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The linking of detailed information on health, medical care, and insurance to economic outcomes is a central feature of data collection efforts in the economics of aging. In this paper, I use newly available linked panel data from a unique supplement to the Health and Retirement Study (HRS) known as the Prescription Drug Study (PDS) to examine the impact of insurance coverage on prescription drug utilization for those 65 and older. Fixed-effect estimates suggest that gaining coverage resulted in a 15% increase in utilization. Gaining coverage also was associated with a 20-50% reduction in the incidence of cost-related non-adherence. However, even among the uninsured, only a relatively small proportion of drugs (12%) were associated with episodes of cost-related non-adherence.\",\"PeriodicalId\":53705,\"journal\":{\"name\":\"Journal of Economic and Social Measurement\",\"volume\":\"41 1\",\"pages\":\"49-65\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.3233/JEM-150418\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Economic and Social Measurement\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3233/JEM-150418\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Social Sciences\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Economic and Social Measurement","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/JEM-150418","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Social Sciences","Score":null,"Total":0}

引用次数: 3

摘要

将健康、医疗保健和保险的详细信息与经济结果联系起来，是老龄化经济学中数据收集工作的一个核心特征。在本文中，我使用来自健康与退休研究(HRS)的独特补充的最新可用链接面板数据，即处方药研究(PDS)，以检查保险覆盖范围对65岁及以上老年人处方药使用的影响。固定效应估计表明，增加覆盖可使利用率提高15%。获得覆盖率还与降低20-50%与费用相关的不依从发生率相关。然而，即使在没有保险的人群中，也只有相对较小比例的药物(12%)与费用相关的不遵守事件有关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Prescription drug coverage and drug utilization: New evidence from the HRS prescription drug study

The linking of detailed information on health, medical care, and insurance to economic outcomes is a central feature of data collection efforts in the economics of aging. In this paper, I use newly available linked panel data from a unique supplement to the Health and Retirement Study (HRS) known as the Prescription Drug Study (PDS) to examine the impact of insurance coverage on prescription drug utilization for those 65 and older. Fixed-effect estimates suggest that gaining coverage resulted in a 15% increase in utilization. Gaining coverage also was associated with a 20-50% reduction in the incidence of cost-related non-adherence. However, even among the uninsured, only a relatively small proportion of drugs (12%) were associated with episodes of cost-related non-adherence.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Economic and Social Measurement Social Sciences-Social Sciences (all)

CiteScore

1.60

自引率

0.00%

发文量

期刊介绍： The Journal of Economic and Social Measurement (JESM) is a quarterly journal that is concerned with the investigation of all aspects of production, distribution and use of economic and other societal statistical data, and with the use of computers in that context. JESM publishes articles that consider the statistical methodology of economic and social science measurements. It is concerned with the methods and problems of data distribution, including the design and implementation of data base systems and, more generally, computer software and hardware for distributing and accessing statistical data files. Its focus on computer software also includes the valuation of algorithms and their implementation, assessing the degree to which particular algorithms may yield more or less accurate computed results. It addresses the technical and even legal problems of the collection and use of data, legislation and administrative actions affecting government produced or distributed data files, and similar topics. The journal serves as a forum for the exchange of information and views between data producers and users. In addition, it considers the various uses to which statistical data may be put, particularly to the degree that these uses illustrate or affect the properties of the data. The data considered in JESM are usually economic or social, as mentioned, but this is not a requirement; the editorial policies of JESM do not place a priori restrictions upon the data that might be considered within individual articles. Furthermore, there are no limitations concerning the source of the data.